timely

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

MILAN, Italy, June 06, 2025 – Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation…

4 weeks ago

Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F

June 02, 2025 19:30 ET  | Source: Semilux International Ltd. Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International…

1 month ago

Celularity Receives Nasdaq Notice Regarding Form 10-Q

May 30, 2025 17:30 ET  | Source: Celularity Inc. FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc.…

1 month ago